Lucid Diagnostics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	34.71	22.36	18.9	22.47	53.66
Cash & Short-Term Investments	34.71	22.36	18.9	22.47	53.66
Cash Growth	55.22%	18.32%	-15.92%	-58.12%	48238.74%
Accounts Receivable	0.64	0.05	0.05	0.02	0.2
Inventory	0.35	0.34	0.28	0.11	-
Other Current Assets	1.77	2.4	2.85	1.75	3.45
Total Current Assets	37.47	25.15	22.07	24.36	57.3
Net Property, Plant & Equipment	2.62	3.7	2.64	3.6	0.97
Other Intangible Assets	0.32	0.74	1.42	3.45	-
Other Long-Term Assets	0.05	1.13	1.13	1.11	0.73
Total Assets	40.45	30.72	27.27	32.51	59
Accounts Payable	0.97	1.24	1.15	1.06	1.49
Accrued Expenses	2.72	2.83	3.84	1.45	1.11
Short-Term Debt	24	18.6	13.95	-	-
Current Portion of Leases	0.89	0.85	1.11	0.96	-
Other Current Liabilities	-	-	9.34	4.96	1.66
Total Current Liabilities	28.58	23.52	29.38	8.43	4.26
Long-Term Leases	0.93	1.8	0.2	1.04	-
Total Long-Term Liabilities	0.93	1.8	0.2	1.04	-
Total Liabilities	29.51	25.32	29.58	9.46	4.26
Preferred Stock	54.27	54.42	18.63	-	-
Common Stock	0.13	0.06	0.04	0.04	0.04
Additional Paid-in Capital	230.87	154.68	129.76	121.08	96.61
Retained Earnings	-274.34	-203.77	-150.74	-98.08	-41.9
Shareholders' Equity	10.94	5.39	-2.31	23.05	54.74
Total Liabilities & Equity	40.45	30.72	27.27	32.51	59
Total Debt	25.82	21.25	15.26	2	0
Net Cash (Debt)	8.89	1.1	3.64	20.48	53.66
Net Cash Growth	704.80%	-69.68%	-82.22%	-61.84%	48238.74%
Net Cash Per Share	0.09	0.02	0.07	0.33	2.00
Book Value	10.94	5.39	-2.31	23.05	54.74
Book Value Per Share	0.11	0.11	-0.05	0.37	2.04
Tangible Book Value	10.62	4.66	-3.74	19.6	54.74
Tangible Book Value Per Share	0.10	0.09	-0.07	0.31	2.04

Updated Mar 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q